Liposome

Type: Keyphrase

Name: Liposome

First Reported May 18 2012 - Updated May 18 2012 - 1 Documents

Reports from L. Simeone and Co-Researchers Add New Data to Research in Liposomes

-- Fresh data on Liposomes are presented in the report "Cholesterol-based nucleolipid-ruthenium complex stabilized by lipid aggregates for antineoplastic therapy. 'A novel ruthenium complex, linked to a cholesterol-containing nucleolipid (named ToThyCholRu), ... [ Published May 18 2012 by NewsRX ]

Entities: Liposomes, Ruthenium, antineoplastic

First Reported May 18 2012 - Updated May 18 2012 - 1 Documents

Systemic Delivery Systems of Angiogenic Gene by Novel Bubble Liposomes Containing Cationic Lipid and Ultrasound Exposure

Recently, we developed polyethyleneglycol (PEG)-modified liposomes (Bubble liposomes; BLs) entrapping ultrasound (US) gas and reported that the combination of BL and US exposure was an effective tool for the delivery of pDNA directly into skeletal muscles ... [ Published May 18 2012 by Molecular Pharmaceutics ]

Entities: Liposomes, Ultrasound, Lipid, Liposome, Exposure

First Reported May 17 2012 - Updated May 17 2012 - 1 Documents

BIO-PATH HOLDINGS INC: Bio-Path Holdings Reports First Quarter 2012 Operational and Financial Results

- Quarter Highlighted by Progress with Lead Product Candidate, Liposomal Grb-2 -Bio-Path Holdings, Inc. (OTC BB: BPTH) ("Bio-Path"), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational ... [ Published May 17 2012 by 4 Traders ]

Entities: BIO-PATH HOLDINGS INC, liposomal, Clinical trials, Nucleic Acid

First Reported May 17 2012 - Updated May 17 2012 - 1 Documents

University of South Australia

Simulated digestion: nanomaterials improve drug absorption

For example, the body only absorbs fat-soluble vitamins A and D in the presence of some fat. Also, the bioavailability of many poorly water-soluble drugs increases when they are taken with high-fat meals. There are many techniques for the lipid-based ... [ Published May 17 2012 by Nanotechnology News ]

Entities: Absorption, Digestion, Decomposition, University of South Australia, Liposome

First Reported May 16 2012 - Updated May 16 2012 - 1 Documents

The Skinny on Skinny-Derm™

Consumers with cellulite looking to target a few problem areas now have direct access to the power of liposome technology with the release of Skinny-Derm™ Mesotherapy Cream by Preventics Health, LLC. This novel skin enhancement treatment is the second ... [ Published May 16 2012 by MoneyShow.com ]

Entities: Choline, Liposome, Hyaluronic Acid

First Reported May 15 2012 - Updated May 15 2012 - 1 Documents

Food and Drug Administration

TALON THERAPEUTICS, INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

We are a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. We currently have four product candidates in various stages of development:? ... [ Published May 15 2012 by Pharmacy Choice ]

Entities: Marqibo, Food and Drug Administration, Clinical trials, Acute Lymphoblastic Leukemia, Talon Therapeutics Inc

First Reported May 11 2012 - Updated May 11 2012 - 1 Documents

Construction of a Gene Screening System Using Giant Unilamellar Liposomes and a Fluorescence-Activated Cell Sorter

We have constructed a gene screening system composed of an in vitro transcription–translation system encapsulated within giant unilamellar liposomes and a fluorescence-activated cell sorter (FACS), which allows high-throughput screening of genes encoding ... [ Published May 11 2012 by Analytical Chemistry ]

Entities: Liposome, Liposomes, Enrichment, Encryption

First Reported May 10 2012 - Updated May 11 2012 - 3 Documents

Oxford Finance Provides $27.5 Million Debt Financing Facility to Pacira Pharmaceuticals

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection the ... [ Published May 10 2012 by 9&10 News ]

Entities: Oxford Finance Corporation, EXPAREL, Bupivacaine, Pacira Pharmaceuticals Inc

First Reported May 03 2012 - Updated May 03 2012 - 2 Documents

Pacira secures $27.5 million debt financing facility

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it has secured a $27.5 million debt financing facility through Oxford Finance. Pacira will use the proceeds from this financing to refinance the remaining principal of its outstanding term ... [ Published May 03 2012 by News-Medical.Net ]

Entities: EXPAREL, Oxford Finance Corporation, Refinancing

First Reported May 02 2012 - Updated May 03 2012 - 2 Documents

PACIRA PHARMACEUTICALS INC: Pacira Pharmaceuticals, Inc. Completes $27.5 Million Debt Refinancing

Terms Defer Principal Repayment and Lock In Lower Interest RatePacira Pharmaceuticals, Inc.(NASDAQ:PCRX) today announced that it has secured a $27.5 million debt financing facility through Oxford Finance. Pacira will use the proceeds from this financing ... [ Published May 03 2012 by 4 Traders ]

Entities: Pacira Pharmaceuticals Inc, EXPAREL, Refinancing

First Reported May 01 2012 - Updated May 01 2012 - 1 Documents

Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.

-Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.Proc Natl Acad Sci U S A. 2012 Apr 25;Authors: Greco E, Quintiliani G, Santucci MB, Serafino A, Ciccaglione AR, Marcantonio C, Papi M, Maulucci ... [ Published May 01 2012 by HIV Atlas ]

Entities: Liposome, Mycobacterium Tuberculosis, immune response, phagocyte

First Reported Apr 27 2012 - Updated Apr 27 2012 - 2 Documents

Higher Costs Hurt Gilead - Analyst Blog

Gilead Sciences, Inc.’s ( GILD ) first quarter 2012 earnings (excluding special items but including stock option expense) of 61 cents per share fell well short of the Zacks Consensus Estimate of 92 cents. Also, first-quarter adjusted earnings decreased ... [ Published Apr 27 2012 by Zacks.com ]

Entities: Antiviral, Ambrisentan, Atripla, Truvada

Quotes

...business in recognition of their product mixmix in the hazardous drug area," said John Farris, president and CEO of SafeBridge Consultants, Inc. "They have been known to us for several years as leaders in the area of containment of oncology drug product manufacturing and the certification of their facilities demonstrates this fact."

: Baxter Facilities Recognized for Safe Handling of Potent Compounds [Individual.com - May 21 2012]

"The resulting nanoaggregates contain up to 15% in moles of the ruthenium complex, and are shown to be..."

Reports from L. Simeone and Co-Researchers Add New Data to Research in Liposomes [NewsRX - May 18 2012]

More Content

sort by: Date \| Relevance
Elimay Supplements Inc. Sponsors a National Can... [ Published 3 hours ago by PRWeb ]
Talon Therapeutics Appoints Head of Commercial ... [ Published 3 hours ago by Morningstar.com ]
: Baxter Facilities Recognized for Safe Handlin... [ Published May 21 2012 by Individual.com ]
PACIRA PHARMACEUTICALS INC: Pacira Pharmaceutic... [ Published May 21 2012 by 4 Traders ]
Pacira Pharmaceuticals, Inc. to Be Added to NAS... [ Published May 21 2012 by MarketWatch ]
Reports from L. Simeone and Co-Researchers Add ... [ Published May 18 2012 by NewsRX ]
New Post-Surgery Pain Medication Recently Launc... [ Published May 18 2012 by Plastic Surgery Channel ]
Ultrasound Imaging of Oxidative Stress In Vivo ... [ Published May 18 2012 by Bionity.com ]
Systemic Delivery Systems of Angiogenic Gene by... [ Published May 18 2012 by Molecular Pharmaceutics ]
Bio-Path Holdings Reports First Quarter 2012 Op... [ Published May 17 2012 by Business Wire ]
BIO-PATH HOLDINGS INC: Bio-Path Holdings Report... [ Published May 17 2012 by 4 Traders ]
Simulated digestion: nanomaterials improve drug... [ Published May 17 2012 by Nanotechnology News ]
Propylene Glycol Liposomes as a Topical Deliver... [ Published May 17 2012 by Bionity.com ]
The Skinny on Skinny-Derm™ [ Published May 16 2012 by MoneyShow.com ]
EKR Therapeutics, Inc. - Strategic SWOT Analysi... [ Published May 16 2012 by PR inside ]
Oxford Finance Closes $27.5 Million Debt Financ... [ Published May 16 2012 by Pharmacy Choice ]
Mechanistic stoichiometry of proton translocati... [ Published May 16 2012 by Bionity.com ]
BIOCUREX INC - 10-Q - MANAGEMENT'S DISCUSSION A... [ Published May 15 2012 by TMC Net ]
TALON THERAPEUTICS, INC. - 10-Q - MANAGEMENT'S ... [ Published May 15 2012 by Pharmacy Choice ]
Application resubmitted for study of ThermoDox ... [ Published May 15 2012 by MedicalPhysicsWeb ]
Citations [ Published May 15 2012 by Bio Techniques ]
Celsion Reports First Quarter 2012 Financial Re... [ Published May 15 2012 by Individual.com ]
Morinda Bioactives launches Shield Biomedicals [ Published May 14 2012 by New Hope 360 ]
Emerson Elementary student Claire Martin wins d... [ Published May 12 2012 by Cleveland Live ]
Biotechnology: Studies from Victor Chang Cardia... [ Published May 12 2012 by NewsRX ]
Construction of a Gene Screening System Using G... [ Published May 11 2012 by Analytical Chemistry ]
Oxford Finance Provides $27.5 Million to Pacira... [ Published May 11 2012 by ABF Journal ]
Oxford Finance Provides $27.5 Million Debt Fina... [ Published May 10 2012 by 9&10 News ]
Biogen Announces US and EU Authorities Accept O... [ Published May 10 2012 by Proactive Investors USA ]
PACIRA PHARMACEUTICALS INC: Oxford Finance Prov... [ Published May 10 2012 by 4 Traders ]

sort by: Date \| Relevance
Pacira launches EXPAREL in US [ Published Apr 09 2012 by PBR - News ] Pacira Pharmaceuticals, a specialty pharmaceutical company, has launched EXPAREL (bupivacaine liposome injectable suspension) in the US. ...
2012 ProteOn Webinar Series [ Published Mar 27 2012 by Canadian BioTechnologist2.0 ] Bio-Rad Laboratories is please to announce its fourth annual ProteOn webinar series. Whether you are new to the field of SPR, or a long-time user, there is sure to be something in this series to be of interest. Here is a list of topics and dates to ...
Galen acquires daunorubicin citrate liposome in... [ Published Feb 24 2012 by PBR - News ] Galen has acquired the chemotherapy agent, DaunoXome (daunorubicin citrate liposome injection) for advanced HIV-associated Kaposi's Sarcoma, from Gilead Sciences. ...
5 Risky Biotech Stocks To Avoid, 2 To Consider [ Published Jan 18 2012 by Healthcare Sector and Stocks Analysis from Seek ... ] By Dividend Kings : This articles continues my focus on biotechnology stocks. I have included a table for each stock to aid us in staying on point. These biotech have an upside catalyst, making them great candidates for further diligence. Gilead ...
Pacira reports Phase 3 study results of Exparel [ Published Dec 20 2011 by PBR - News ] Pacira Pharmaceuticals' Exparel (bupivacaine liposome injectable suspension), a non-opioid local analgesic, for administration into the surgical site to produce postsurgical analgesia has reported pain reduction in a pivotal Phase 3 trial. ...